Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. [NA]

View source ↗

Summary

A non-inferiority clinical trial compares salvage pelvic radiotherapy given in 25 fractions (62.5 Gy) versus 20 fractions (52.5 Gy) for recurrent prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy) | NA | Status: NOT_YET_RECRUITING